Waters (NYSE:WAT – Get Free Report) updated its fourth quarter earnings guidance on Friday. The company provided earnings per share (EPS) guidance of $3.90-4.10 for the period, compared to the consensus estimate of $4.09. The company issued revenue guidance of +3.3-5.3% yr/yr to ~$846.5-862.9, compared to the consensus revenue estimate of $854.35 million. Waters also updated its FY 2024 guidance to 11.670-11.870 EPS.
Waters Stock Performance
NYSE WAT traded down $4.95 during trading hours on Monday, reaching $382.26. The company’s stock had a trading volume of 363,136 shares, compared to its average volume of 428,831. Waters has a 52 week low of $241.95 and a 52 week high of $391.00. The stock has a market cap of $22.69 billion, a PE ratio of 36.94, a PEG ratio of 6.35 and a beta of 0.97. The company has a current ratio of 2.10, a quick ratio of 1.42 and a debt-to-equity ratio of 1.42. The business has a 50-day simple moving average of $342.04 and a 200 day simple moving average of $325.28.
Waters (NYSE:WAT – Get Free Report) last announced its earnings results on Friday, November 1st. The medical instruments supplier reported $2.93 EPS for the quarter, topping the consensus estimate of $2.68 by $0.25. Waters had a return on equity of 56.81% and a net margin of 20.71%. The firm had revenue of $740.30 million for the quarter, compared to analysts’ expectations of $712.99 million. During the same quarter in the previous year, the company earned $2.84 earnings per share. The firm’s quarterly revenue was up 4.0% compared to the same quarter last year. Equities research analysts predict that Waters will post 11.6 earnings per share for the current fiscal year.
Analysts Set New Price Targets
View Our Latest Stock Analysis on Waters
About Waters
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
Featured Stories
- Five stocks we like better than Waters
- Basic Materials Stocks Investing
- Intel: Is Now the Time to Be Brave?
- Stock Market Sectors: What Are They and How Many Are There?
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- Stock Average Calculator
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.